The immediate focus of this dispute centers on the US AI Safety Institute (USASI), which is currently conducting an extended evaluation of Claude Fable 5. According to industry insiders, the institute has requested an additional 90-day testing window to probe the model's capacity for autonomous cyber operations and advanced chemical synthesis. Anthropic has resisted this extension, citing its strict internal safety protocols and the commercial pressure to match rival offerings from OpenAI and Google.
Over the next few weeks, negotiations are expected to intensify behind closed doors. The White House is attempting to secure a legally binding agreement that would give federal agencies veto power over specific model capabilities before public deployment. This indicates a shift in Washington's strategy, moving away from broad industry oversight toward direct, model-by-model intervention. Anthropic, structured as a Public Benefit Corporation, faces a delicate balancing act: it must preserve its reputation as the industry's safety leader while satisfying its primary financial backers, Amazon and Google, who have poured billions into the company with the expectation of market-leading enterprise tools.
If these talks fail, the dispute could spill into the public arena, potentially forcing the administration to test the limits of its executive authority under the Defense Production Act. Such a move would trigger a complex legal battle over whether the government can treat software code as a critical national resource subject to federal seizure or restriction.
